These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Coffee and liver health. Morisco F; Lembo V; Mazzone G; Camera S; Caporaso N J Clin Gastroenterol; 2014; 48 Suppl 1():S87-90. PubMed ID: 25291138 [TBL] [Abstract][Full Text] [Related]
3. Hepatocarcinogenesis in non-alcoholic fatty liver disease in Japan. Tokushige K; Hashimoto E; Kodama K J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():88-92. PubMed ID: 24251711 [TBL] [Abstract][Full Text] [Related]
4. Impact of coffee on liver diseases: a systematic review. Saab S; Mallam D; Cox GA; Tong MJ Liver Int; 2014 Apr; 34(4):495-504. PubMed ID: 24102757 [TBL] [Abstract][Full Text] [Related]
5. [Coffee can be beneficial for patients with liver diseases]. Kjærgaard M; Thiele M; Krag A Ugeskr Laeger; 2014 Oct; 176(43):. PubMed ID: 25353679 [TBL] [Abstract][Full Text] [Related]
6. [Coffee as hepatoprotective factor]. Szántová M; Ďurkovičová Z Vnitr Lek; 2016; 62(12):990-997. PubMed ID: 28139128 [TBL] [Abstract][Full Text] [Related]
9. Coffee and the liver: a potential treatment for liver disease? Masterton GS; Hayes PC Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1277-83. PubMed ID: 20802342 [TBL] [Abstract][Full Text] [Related]
10. Molecular Bases Underlying the Hepatoprotective Effects of Coffee. Salomone F; Galvano F; Li Volti G Nutrients; 2017 Jan; 9(1):. PubMed ID: 28124992 [TBL] [Abstract][Full Text] [Related]
11. Role of diet and nutritional management in non-alcoholic fatty liver disease. Fan JG; Cao HX J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():81-7. PubMed ID: 24251710 [TBL] [Abstract][Full Text] [Related]
12. Characteristics and diagnosis of NAFLD/NASH. Hashimoto E; Taniai M; Tokushige K J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707 [TBL] [Abstract][Full Text] [Related]
13. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Bravi F; Bosetti C; Tavani A; Gallus S; La Vecchia C Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1413-1421.e1. PubMed ID: 23660416 [TBL] [Abstract][Full Text] [Related]
14. Effect of Coffee Consumption on Non-Alcoholic Fatty Liver Disease Incidence, Prevalence and Risk of Significant Liver Fibrosis: Systematic Review with Meta-Analysis of Observational Studies. Ebadi M; Ip S; Bhanji RA; Montano-Loza AJ Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578919 [TBL] [Abstract][Full Text] [Related]
15. Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease. Yesil A; Yilmaz Y Aliment Pharmacol Ther; 2013 Nov; 38(9):1038-44. PubMed ID: 24024834 [TBL] [Abstract][Full Text] [Related]
16. Coffee and nonalcoholic fatty liver disease: A review. Nikrandt G; Chmurzynska A Acta Sci Pol Technol Aliment; 2020; 19(3):245-254. PubMed ID: 32978907 [TBL] [Abstract][Full Text] [Related]
17. Caffeine is protective in patients with non-alcoholic fatty liver disease. Birerdinc A; Stepanova M; Pawloski L; Younossi ZM Aliment Pharmacol Ther; 2012 Jan; 35(1):76-82. PubMed ID: 22059453 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. Baffy G; Brunt EM; Caldwell SH J Hepatol; 2012 Jun; 56(6):1384-91. PubMed ID: 22326465 [TBL] [Abstract][Full Text] [Related]
19. Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies. Marventano S; Salomone F; Godos J; Pluchinotta F; Del Rio D; Mistretta A; Grosso G Clin Nutr; 2016 Dec; 35(6):1269-1281. PubMed ID: 27060021 [TBL] [Abstract][Full Text] [Related]